Here are relevant reports on : single-use-bioreactors-market
-
Single-use Bioreactors Market by Product (Systems, Bags, Assemblies), Type (Stirred Tank, Bubble-Column, Wave induced), Molecule (mAbs, Vaccines), Cell Type (Mammalian, Bacterial, Yeast), Application (R&D, Bioproduction) - Global Forecast to 2029
The global single-use bioreactors market, valued at US$4.1 billion in 2023, stood at US$4.4 billion in 2024 and is projected to advance at a resilient CAGR of 15.4% from 2024 to 2029, culminating in a forecasted valuation of US$9.1 billion by the end of the period. Advantages over conventional bioreactors, lower capital investment, reduced water and energy usage, the expanding biologics and biosimilars markets, and increased adoption among CDMOs, CMOs, and SMEs are some of the factors driving market growth.
- Published: August 2024
- Price: $ 4950
- TOC Available:
-
Single-use Bioprocessing Market by Product (Equipment [Bioreactors, Filtration, Chromatography], Consumables [Filters, Bags, Assemblies, Sensors]), Application (Storage, Mixing), Workflow (Upstream), Molecule Type (mAbs, Vaccines) - Global Forecast to 2030
The global single-use bioprocessing market, valued at US$16.51 billion in 2024, stood at US$18.01 billion in 2025 and is projected to advance at a resilient CAGR of 13.3% from 2024 to 2030, culminating in a forecasted valuation of US$33.67 billion by the end of the period. The single-use bioprocessing market is witnessing significant expansion due to the increasing adoption of disposable technologies in the biopharmaceutical sector.
- Published: October 2025
- Price: $ 7150
- TOC Available:
-
Cell Expansion Market by Product (Consumables (Media, Sera, Reagents, Vessels), Equipment (Cell Expansion Systems, Bioreactors, Incubators)), Cell Type (Human, Animal (CHO, mESCs)), Application (Vaccines, mAbs, CGT), End User - Global Forecast to 2029
The global cell expansion market, valued at US$12.7 billion in 2023, stood at US$14.3 billion in 2024 and is projected to advance at a resilient CAGR of 13.3% from 2024 to 2029, culminating in a forecasted valuation of US$26.7 billion by the end of the period. Growth of the cell expansion market can be attributed to factors such as the booming biopharmaceutical industry, increased investments in research and development for the advancement of biopharmaceutical industry, rising need of advanced biopharmaceuticals, and increasing GMP certification for cell therapy manufacturing facilities.
- Published: March 2024
- Price: $ 4950
- TOC Available:
-
Biotechnology Instruments Market by Product (LC, NGS, Mass Spectrometry, Electrophoresis, Bioreactors, Incubators, Centrifuges, Spectrophotometers), Application (Biotech Manufacturing, Spatial Cell Analysis, Genomics, Proteomics), End User (Biopharma Cos, CROs, Academia) - Global Forecasts to 2027
The global biotechnology instruments market is projected to reach USD 35.9 billion by 2027 from USD 21.4 billion in 2022, at a CAGR of 9% during the forecast period
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Cell Culture Market by Product (Consumables (Media, Sera, Reagent, Vessels (Roller bottle, Flask, Cell Factory)), Equipment (Bioreactors, Centrifuges, Filtration, Incubators, Freezers)), Application (mAbs, Vaccines, CGT), End User - Global Forecast to 2030
The global cell culture market, valued at US$27.92 billion in 2024, stood at US$29.76 billion in 2025 and is projected to advance at a resilient CAGR of 11.2% from 2025 to 2030, culminating in a forecasted valuation of US$50.69 billion by the end of the period. Growing opportunities in emerging economies and advancements in 2D and 3D cell culture technology is likely to offer potential growth opportunities in the cell culture market.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Bioprocess Validation Market by Test Type (Extractables and Leachables, Integrity Testing, Microbiology Testing), Process Component (Filter Element, Bioreactors), End-User (CDMO, Biotechnology & Pharmaceutical Companies) & Region - Global Forecasts to 2024
The global bioprocess validation market size is projected to reach USD 360 million by 2024, at a CAGR of 14.6%. The prominent players operating in this market are Merck KGaA (Germany), Sartorius Stedim Biotech (Sartorius AG) (France), Pall Corporation (US), SGS S.A. (Switzerland), Eurofins Scientific (Luxembourg), Cobetter Filtration Equipment Co., Ltd. (China), Toxikon Corporation (US), DOC S.r.l. (Italy), MEISSNER FILTRATION PRODUCTS, INC. (US), and Thermo Fisher Scientific (US).
- Published: July 2019
- Price: $ 4950
- TOC Available:
-
Gyros FOG / RLG Market (Single Axis, Multiple Axis), By Products, Technology, Application & Geography - 2019
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
SNP (Single Nucleotide Polymorphism) Market: Genotyping and Analysis, Future of SNPs in Personalized Medicine (2011-2016)
SNP (Single Nucleotide Polymorphism) genotyping is a measurement of genetic variations. It is the most common type of genetic variation between humans. Specific single base pair mutations are ideal for identifying correlation between genotype and human behavior.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Single Use Transfer Mats Market
Non-mechanical equipment or soft products are used with or without mechanical equipment to transfer or relocate a patient. Non-mechanical devices comprise slide sheets, transfer belts, roller sheets and single-use patient transfer mats. Slide sheets, designed to reduce friction between surfaces, aid in transferring patients from one bed to another. Transfer belts worn by patients provide caregivers with a safe and secure grip. These devices are not only safe and comfortable for patients but also beneficial for caregivers as they reduce the risk of injuries during patient transfers/relocation.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Single Mode Fiber Market - By Type, Application & Geography - 2018
- Published: January 2026
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
